Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:1814-1821

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molenaar, P.
Right arrow Articles by Kaumann, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molenaar, P.
Right arrow Articles by Kaumann, A.
Related Collections
Right arrow Contractile function
Right arrow Cardiac development

(Circulation. 2000;102:1814.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Both ß2- and ß1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of ß2-Adrenergic Receptors to Gs-Protein

Peter Molenaar, PhD; Sabine Bartel, PhD; Andrew Cochrane, MBBS, FRACS; Donathe Vetter, TA; Homayoun Jalali, MD; Peter Pohlner, MBBS, FRACS; Kylie Burrell, BScHons; Peter Karczewski, PhD; Ernst-Georg Krause, PhD; Alberto Kaumann, MD, PhD

From the Departments of Medicine, The Prince Charles Hospital; Physiology and Pharmacology, University of Queensland, Queensland (P.M.); the Department of Pharmacology, University of Melbourne, Victoria, Australia (P.M., K.B.); Max-Delbrück Center of Molecular Medicine, Cardiology, Berlin, Germany (S.B., D.V., P.K., E.G.K.); Victorian Paediatric Cardiac Surgical Unit, Royal Children’s Hospital, Parkville, Australia (A.C.); the Department of Cardiac Surgery, The Prince Charles Hospital, Queensland (H.J., P.P.); Babraham Institute, Cambridge, and the Department of Physiology, University of Cambridge, UK (A.K.).

Correspondence to Dr Peter Molenaar, Department of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, Queensland, 4032, Australia. E-mail molenaar{at}medicine.uq.edu.au

Background—In adult human heart, both ß1- and ß2-adrenergic receptors mediate hastening of relaxation; however, it is unknown whether this also occurs in infant heart. We compared the effects of stimulation of ß1- and ß2-adrenergic receptors on relaxation and phosphorylation of phospholamban and troponin I in ventricle obtained from infants with tetralogy of Fallot.

Methods and Results—Myocardium dissected from the right ventricular outflow tract of 27 infants (age range 21/2 to 35 months) with tetralogy of Fallot was set up to contract 60 times per minute. Selective stimulation of ß1-adrenergic receptors with (-)-norepinephrine (NE) and ß2-adrenergic receptors with (-)-epinephrine (EPI) evoked phosphorylation of phospholamban (at serine-16 and threonine-17) and troponin I and caused concentration-dependent increases in contractile force (-log EC50 [mol/L] NE 5.5±0.1, n=12; EPI 5.6±0.1, n=13 patients), hastening of the time to reach peak force (-log EC50 [mol/L] NE 5.8±0.2; EPI 5.8±0.2) and 50% relaxation (-log EC50 [mol/L] NE 5.7±0.2; EPI 5.8±0.1). Ventricular membranes from Fallot infants, labeled with (-)-[125I]-cyanopindolol, revealed a greater percentage of ß1- (71%) than ß2-adrenergic receptors (29%). Binding of (-)-epinephrine to ß2-receptors underwent greater GTP shifts than binding of (-)-norepinephrine to ß1-receptors.

Conclusions—Despite their low density, ß2-adrenergic receptors are nearly as effective as ß1-adrenergic receptors of infant Fallot ventricle in enhancing contraction, relaxation, and phosphorylation of phospholamban and troponin I, consistent with selective coupling to Gs-protein.


Key Words: tetralogy of Fallot • catecholamines • myocardial contraction • receptors, adrenergic, beta




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Ryall, J. D. Schertzer, K. T. Murphy, A. M. Allen, and G. S. Lynch
Chronic {beta}2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2587 - H2595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner
Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Molenaar, T. Christ, U. Ravens, and A. Kaumann
Carvedilol blocks {beta}2- more than {beta}1-adrenoceptors in human heart
Cardiovasc Res, January 1, 2006; 69(1): 128 - 139.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. F. Heubach, U. Ravens, and A. J. Kaumann
Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart
Mol. Pharmacol., May 1, 2004; 65(5): 1313 - 1322.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. J. Lohse, S. Engelhardt, and T. Eschenhagen
What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?
Circ. Res., November 14, 2003; 93(10): 896 - 906.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Bartel, E.-G. Krause, G. Wallukat, and P. Karczewski
New insights into {beta}2-adrenoceptor signaling in the adult rat heart
Cardiovasc Res, March 1, 2003; 57(3): 694 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Kilts, T. Akazawa, M. D. Richardson, and M. M. Kwatra
Age Increases Cardiac Galpha i2 Expression, Resulting in Enhanced Coupling to G Protein-coupled Receptors
J. Biol. Chem., August 16, 2002; 277(34): 31257 - 31262.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Lohse and S. Engelhardt
Protein Kinase A Transgenes: The Many Faces of cAMP
Circ. Res., November 23, 2001; 89(11): 938 - 940.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Devic, Y. Xiang, D. Gould, and B. Kobilka
beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice
Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583.
[Abstract] [Full Text] [PDF]